Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
The money raised through the Offer for Sale goes to existing investors, not the company.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
No peer comparisons added yet.
Sagility India Limited is a healthcare focused business process management company that serves the United States healthcare industry. It works with two kinds of clients: Payers, meaning health insurers who fund and reimburse the cost of care, and Providers, meaning hospitals, physician groups, laboratories and medical device companies. For Payers the company handles functions such as claims administration, enrollment and clinical support, while for Providers it manages revenue cycle related tasks such as billing and collections. The company was incorporated in 2021 and traces its roots to a carve out of a healthcare services business that has served US healthcare clients for many years. It operates through a global delivery network spanning more than thirty locations across India, the Philippines, the United States, Jamaica and Colombia, and employs a workforce of well over thirty thousand people, with women making up a majority of that workforce. Its client base includes several of the ten largest health insurers in the United States, and the company has continued to add new client relationships in recent years. Sagility operates in the specialised segment of technology enabled services for the healthcare payer and provider ecosystem, a market it describes as large and relatively resilient because healthcare spending tends to continue regardless of broader economic cycles. Its growth is driven by insurers and hospital systems increasingly outsourcing non-core administrative and clinical-support functions to reduce cost and improve efficiency, a trend the company aims to keep benefiting from through deeper existing relationships and new client additions.
Ahead of the issue opening, the company raised about Rs 945 crore from anchor investors through the allotment of shares at the IPO price of Rs 30 per share, representing a significant majority of the institutional portion of the offering.
Source: RHP • Analysis provided for informational purposes
Last Updated: 14 July 2026, 5:30 AM
Focused leader in a resilient niche
The company concentrates entirely on technology enabled services for US healthcare payers and providers, a market that tends to hold up well through economic cycles because healthcare spending is largely non discretionary.
Deep, long standing client relationships
It counts several of the ten largest US health insurers among its clients and has continued to add new client relationships in recent years, reflecting sticky, recurring engagements.
Large, diversified global delivery footprint
Operations span more than thirty delivery locations across India, the Philippines, the US, Jamaica and Colombia with a workforce of over thirty five thousand people, giving it scale and geographic redundancy.
End to end service offering
The company serves both sides of the healthcare value chain, claims and clinical support for payers and revenue cycle management for providers, letting it cross sell across a single client relationship.
Reliance on a single industry
Because the business depends entirely on the US healthcare industry, any slowdown in outsourcing activity or adverse healthcare policy shifts could disproportionately affect results.
High employee attrition
The company reported an attrition rate above a quarter of its workforce annually, which raises ongoing recruitment and training costs and could affect service quality.
Credit rating sensitivity
A credit rating downgrade for the company could raise its cost of capital and constrain its ability to fund growth or refinance debt.
Sagility India Limited
No. 23 & 24, AMR Tech Park, Building 2A, First Floor, Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru 560068, Karnataka, India
View on Maps →MUFG Intime India Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.
Goodwill and intangible asset concentration
A meaningful share of the balance sheet consists of goodwill and other intangibles, so any future impairment could weigh materially on reported profitability.
Policy risk around outsourcing
Legislative or regulatory restrictions on outsourcing healthcare administrative work to offshore locations could limit the company's ability to serve its clients from its current delivery locations.
Competitive intensity
The healthcare BPO and services space includes several established players, and intensifying competition could pressure pricing and margins.